Effect on mother and child of eculizumab given before caesarean section in a patient with severe antiphospholipid syndrome: A case report

RATIONALE: Antiphospholipid syndrome (APS) in pregnancy may trigger the life-threatening catastrophic antiphospholipid syndrome (CAPS). Complement activation is implicated in the pathogenesis, and inhibition of complement factor C5 is suggested as an additional treatment option. PATIENT CONCERNS, DI...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Medicine (Baltimore)
Autores principales: Gustavsen, Alice, Skattum, Lillemor, Bergseth, Grethe, Lorentzen, Bjorg, Floisand, Yngvar, Bosnes, Vidar, Mollnes, Tom Eirik, Barratt-Due, Andreas
Formato: Artigo
Lenguaje:Inglês
Publicado: Wolters Kluwer Health 2017
Materias:
6900
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5369917/
https://ncbi.nlm.nih.gov/pubmed/28296762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000006338
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares